Prostate cancer occurs when abnormal cells develop in the prostate gland – part of the male reproductive system – more quickly than in a normal prostate, forming a malignant tumor. Although the causes of the cancer are unknown, there are factors that can increase risk, including age. It is most commonly diagnosed in men aged 60-79.
At HealthMatch, we’re bringing forward tomorrow’s treatments. We have trials actively recruiting prostate cancer patients, including ones aimed at targeted radiotherapy. Immunotherapy and new drugs in hormone treatment.
Let's see the back of prostate cancer for good. Find a prostate cancer clinical trial today.
Create an account and start answering some questions to see what trials match your profile.
Australian men will be diagnosed with prostate cancer in their lifetime¹
of men diagnosed with prostate cancer are over the age of 50²
of all new male cancer cases in 2019 were prostate cancer³
Clinical trials are vital for researchers and physicians to advance modern medicine and improve the quality of life for future patients. All the drugs and medical equipment we use today are available because patients participated in clinical trials.
Our platform helps you find the right match by showing you only trials you’re eligible for and simplifying the jargon. You’re then able to view matches and apply for trials in an easy-to-use dashboard. Once you’ve been accepted, we’ll put you in direct contract with the trial group.
If you don’t match with a clinical trial today, we won’t stop searching until we find the right match for you.
Our community consists of a diverse team of doctors, engineers, scientists, and people dedicated to challenging the status quo of medical research.
We are united by a passion to deliver better healthcare options, for all, regardless of location, background or means. This means access to trials and the revolutionary treatments that come from them.
Prostate cancer is when abnormal cells in the prostate – a small, walnut-shaped gland that sits below the bladder and near the rectum – start growing in an uncontrolled way. This then forms a malignant tumor. For some men it may be slow-growing, for others, it can be aggressive.
Abnormal cells can continue to multiply in an uncontrolled way, and may spread outside the prostate into other parts of the body.
Anyone with a prostate can get prostate cancer – this includes transgender women, male-assigned non-binary people, and intersex people if they have a prostate.
People of older age, with a family history of the cancer, or a strong family history of breast or ovarian cancer are at increased risk of developing the disease.
Early stages of prostate cancer rarely cause symptoms.
At the later stages, symptoms may include a frequent or sudden need to urinate; difficulty urinating; uncomfortable urination; finding blood in urine or semen; pain in the lower back, upper thighs, or hips, and more.
Some people may experience no signs or symptoms, even when at an advanced stage.
There are several forms of treatment and management options for prostate cancer. This includes active surveillance, watchful waiting, radiation therapy, hormone therapy, and chemotherapy.
These options may be used in combination with one another, depending on the situation.
The five-year survival rate for prostate cancer is 95%.
Treatment may slow the growth of the cancer and reduce symptoms. Many treatments can improve survival – meaning many men live for years with advanced prostate cancer.